Less Ads, More Data, More Tools Register for FREE

Pin to quick picksDe La Rue Regulatory News (DLAR)

  • This share is currently suspended. It was suspended at a price of 130.00
  • There is currently no data for DLAR

Trading Update

30 Oct 2019 07:00

RNS Number : 5431R
De La Rue PLC
30 October 2019
 

 

The information contained within this announcement is deemed to constitute inside information as stipulated under the Market Abuse Regulations (EU) No.596/2014. Upon the publication of this announcement, this inside information is now considered to be in the public domain.

30 October 2019

 

 

DE LA RUE PLC

TRADING UPDATE

 

De La Rue plc ("De La Rue") today announces a trading update from 1 April 2019 to date.

 

De La Rue expects H1 2019/20 adjusted operating profits for the half year ended 28th September 2019 to be low-to-mid single digit millions. Full year 2019/20 adjusted operating profit will be significantly lower than market expectations.

 

Management, led by the new CEO, is conducting a detailed review of the business and will update the market further when it reports its H1 2019/20 results on 26 November 2019.

 

De La Rue plc's LEI code is 213800DH741LZWIJXP78

Enquiries:

 

De La Rue plc +44 (0)1256 605322

Paul Sharma Head of Investor Relations

 

Brunswick Group LLP +44 (0)207 404 5959

Azadeh Varzi

Stuart Donnelly

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
TSTPGGQPUUPBPUB
Date   Source Headline
8th Jul 20212:43 pmRNSDirector/PDMR Shareholding
6th Jul 20212:51 pmRNSDirector/PDMR Shareholding
1st Jul 20214:35 pmRNSBlock listing Interim Review
1st Jul 20214:21 pmRNSTotal Voting Rights
1st Jul 20218:00 amRNSDirector/PDMR Shareholding
28th Jun 20213:55 pmRNSHolding(s) in Company
24th Jun 202111:24 amRNSHolding(s) in Company
18th Jun 20211:44 pmRNSAnnual Financial Report
1st Jun 202111:23 amRNSTotal Voting Rights
26th May 20217:00 amRNS2020/21 Full Year Results
13th May 20217:00 amRNSAUTHENTICATION CONTRACT WINS
4th May 20212:07 pmRNSTotal Voting Rights
13th Apr 20217:00 amRNSTrading Statement
1st Apr 20217:00 amRNSTotal Voting Rights
23rd Mar 20215:09 pmRNSHolding(s) in Company
23rd Mar 20217:00 amRNSDirectorate Change
1st Mar 202112:20 pmRNSTotal Voting Rights
1st Feb 202112:37 pmRNSTotal Voting Rights
28th Jan 202112:59 pmRNSHolding(s) in Company
28th Jan 20217:00 amRNSTrading Statement
5th Jan 20219:36 amRNSDirector/PDMR Shareholding
4th Jan 202111:15 amRNSBlock listing Interim Review
4th Jan 202111:12 amRNSTotal Voting Rights
23rd Dec 202012:10 pmRNSDirector/PDMR Shareholding
1st Dec 20202:25 pmRNSTotal Voting Rights
1st Dec 20209:10 amRNSDirector/PDMR Shareholding
25th Nov 20207:00 amRNS2020/21 HALF YEAR RESULTS
4th Nov 20201:45 pmRNSHolding(s) in Company
30th Oct 20207:00 amRNSEXTENSION OF THE BANK OF ENGLAND CONTRACT
21st Oct 202011:32 amRNSHolding(s) in Company
15th Oct 20207:00 amRNSTrading Update
1st Oct 20201:30 pmRNSTotal Voting Rights
1st Oct 20207:00 amRNSChief Financial Officer Appointment
22nd Sep 20207:00 amRNSDirectorate Change
1st Sep 202012:14 pmRNSTotal Voting Rights
24th Aug 20203:05 pmRNSHolding(s) in Company
13th Aug 20207:00 amRNSAppointment of Joint Broker
7th Aug 20204:42 pmRNSHolding(s) in Company
6th Aug 202012:40 pmRNSResult of AGM
6th Aug 20207:00 amRNSAGM Statement
4th Aug 20209:37 amRNSHolding(s) in Company
31st Jul 20203:52 pmRNSTotal Voting Rights
27th Jul 20207:00 amRNSAdditional Listing
22nd Jul 20206:00 pmRNSHolding(s) in Company
16th Jul 20205:12 pmRNSDirector/PDMR Shareholding
15th Jul 20204:13 pmRNSHolding(s) in Company
14th Jul 20203:03 pmRNSHolding(s) in Company
14th Jul 20202:40 pmRNSHolding(s) in Company
13th Jul 20203:18 pmRNSNotice of AGM
13th Jul 20203:13 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.